186 related articles for article (PubMed ID: 15706476)
1. External quality assessment and the laboratory diagnosis of thrombophilia.
Meijer P; Haverkate F
Semin Thromb Hemost; 2005 Feb; 31(1):59-65. PubMed ID: 15706476
[TBL] [Abstract][Full Text] [Related]
2. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
Meijer P; Haverkate F; Kluft C
Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
[TBL] [Abstract][Full Text] [Related]
3. Learning from peer assessment: the role of the external quality assurance multilaboratory thrombophilia test process.
Favaloro EJ
Semin Thromb Hemost; 2005 Feb; 31(1):85-9. PubMed ID: 15706479
[TBL] [Abstract][Full Text] [Related]
4. The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation.
Meijer P; Kluft C; Haverkate F; De Maat MP
J Thromb Haemost; 2003 Apr; 1(4):748-53. PubMed ID: 12871411
[TBL] [Abstract][Full Text] [Related]
5. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance issues and interpretation of assays.
Mackie I; Cooper P; Kitchen S
Semin Hematol; 2007 Apr; 44(2):114-25. PubMed ID: 17433904
[TBL] [Abstract][Full Text] [Related]
7. Laboratory identification of familial thrombophilia: do the pitfalls exceed the benefits? A reassessment of ABO-blood group, gender, age, and other laboratory parameters on the potential influence on a diagnosis of protein C, protein S, and antithrombin deficiency and the potential high risk of a false positive diagnosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
Lab Hematol; 2005; 11(3):174-84. PubMed ID: 16174603
[TBL] [Abstract][Full Text] [Related]
8. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program.
Jennings I; Kitchen S; Woods TA; Preston FE
Semin Thromb Hemost; 2005 Feb; 31(1):66-72. PubMed ID: 15706477
[TBL] [Abstract][Full Text] [Related]
9. Quality control in coagulation testing.
Plebani M; Sanzari MC; Zardo L
Semin Thromb Hemost; 2008 Oct; 34(7):642-6. PubMed ID: 19085764
[TBL] [Abstract][Full Text] [Related]
10. A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia.
Tripodi A
Semin Thromb Hemost; 2005 Feb; 31(1):25-32. PubMed ID: 15706472
[TBL] [Abstract][Full Text] [Related]
11. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
[TBL] [Abstract][Full Text] [Related]
12. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
13. External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia.
Cunningham MT; Olson JD; Chandler WL; Van Cott EM; Eby CS; Teruya J; Hollensead SC; Adcock DM; Allison PM; Kottke-Marchant KK; Smith MD
Arch Pathol Lab Med; 2011 Feb; 135(2):227-32. PubMed ID: 21284443
[TBL] [Abstract][Full Text] [Related]
14. Standardisation of protein S in plasma: calibration of the 1st International Standard.
Hubbard AR
Thromb Haemost; 1997 Oct; 78(4):1237-41. PubMed ID: 9364991
[TBL] [Abstract][Full Text] [Related]
15. [Etiological analysis of thrombophilia].
Tsuda H; Iida H; Nakahara M; Hattori S; Tanabe S; Fujise M; Kinoshita S; Hamasaki N
Rinsho Byori; 1997 Nov; 45(11):1025-30. PubMed ID: 9396341
[TBL] [Abstract][Full Text] [Related]
16. [Domestic and international trends concerning allowable limits of error in external quality assessment scheme].
Hosogaya S; Ozaki Y
Rinsho Byori; 2005 Jun; 53(6):547-53. PubMed ID: 16026083
[TBL] [Abstract][Full Text] [Related]
17. Application of indicators for quality improvement in the coagulation laboratory.
Opartkiattikul N; Wongtiraporn W; Tientadakul P; Rungpitarungsi B
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():131-5. PubMed ID: 12755283
[TBL] [Abstract][Full Text] [Related]
18. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factor.
Favaloro EJ; Bonar R; Survela L; McDonald D; Koutts J; Sioufi J; Marsden K
Lab Hematol; 2007; 13(4):128-34. PubMed ID: 18192144
[TBL] [Abstract][Full Text] [Related]
20. External quality control program for inter-laboratory quality control.
Bewarder N; Müller P
Anticancer Res; 2000; 20(6D):5213-6. PubMed ID: 11326697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
